# Arthro Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arthro-therapeutics

- Industry: Internet
- Headquarters: Malmo, Sweden
- Website: www.jointacademy.com
- Total disclosed funding: $32M
- Latest round: Series B (Sep 17, 2020)
- Investors on record: 7

## About

Arthro Therapeutics AB, operating as Joint Academy, focuses on delivering innovative physical therapy solutions tailored for musculoskeletal conditions, utilizing both virtual and in-person services to enhance patient outcomes.Founded in 2016, Arthro Therapeutics AB, based in Malmo, Sweden, specializes in treating musculoskeletal disorders through personalized therapy solutions. The firm has not undergone any significant pivots and does not have any known subsidiaries. The CEO and founder, Jakob Dahlberg, has a history in the healthcare technology sector. The company has completed a total of 7 funding deals, with the most recent being a Series B round in September 2020, where they raised USD 23.00 mn, led by Kinnevik and supported by Alfvén & Didrikson, among others. This total amount raised is USD 23.00 mn.Joint Academy specializes in providing comprehensive physical therapy solutions through virtual and in-person services, targeting musculoskeletal (MSK) conditions. Their core offering includes personalized treatment plans developed with licensed physical therapists, accessible via the Joint Academy app. Patients across various regions, including the United States and the United Kingdom, benefit from treatment addressing joint and muscle pain, injury rehabilitation, chronic pain management, and recovery from surgeries. The service facilitates direct video consultations with therapists, along with prescribed exercises and educational resources, supporting thousands of patients daily in improving mobility and managing pain.In the most recent fiscal year of 2022, Joint Academy reported a revenue of USD 4,252,063.10, with an EBITDA of USD -8,611,178.70. Revenue generation is primarily through subscription-based models for their physical therapy services, where clients pay for access to personalized treatment plans that include video consultations and ongoing support, with various service levels designed to accommodate different patient needs. The company has also partnered with major insurance providers, allowing broader access to their services under various health plans, thus facilitating a smoother transaction process for patients using insurance benefits.Arthro Therapeutics AB aims to leverage recent Series B funding of USD 23.00 mn, raised in September 2020, to enhance its service offerings and expand into new geographic markets. Plans include developing upcoming products aimed at improving patient engagement and accessibility, although no specific release dates have been disclosed. The company is targeting expansion into additional regions to reach a broader audience, enhancing availability for patients in the coming years. This strategic growth plan is designed to capitalize on recent funding to fuel these initiatives.

## Funding rounds

- Series B, Sep 17, 2020, $23M — Kinnevik, Alfven & Didrikson
- Series A, Sep 6, 2018, $7M — Alfven & Didrikson
- Seed, Dec 6, 2016, $2.2M — Lund University, Sweet Capital, Walking Ventures, Dendera Ventures, Incos Invest
- Seed, Aug 1, 2015 — Incos Invest

## Investors

- Incos Invest (https://capitalatlas.ai/funds/incos-invest) — Seed
- Lund University — Seed
- Sweet Capital (https://capitalatlas.ai/funds/sweet-capital) — Seed
- Walking Ventures (https://capitalatlas.ai/funds/walking-ventures) — Seed
- Dendera Ventures (https://capitalatlas.ai/funds/dendera-ventures) — Seed
- Alfven & Didrikson (https://capitalatlas.ai/funds/alfven-didrikson) — Series A, Series B
- Kinnevik (https://capitalatlas.ai/funds/kinnevik) — Series B